Get started
Work

Clinical development of IL13Rα2-targeting CAR T cells for the treatment of glioblastoma

Year: 2015
Type: article
Abstract: Meeting abstracts T cell immunotherapy is emerging as a powerful strategy to treat cancer, and may offer new opportunities to improve outcomes for patients with glioblastoma (GBM). Our group has developed a chimeric antigen receptor (CAR) T cell immunotherapy for GBM targeting IL-13 receptor α2 (
DOI: 10.1186/2051-1426-3-s2-p114
Authors: Christine E Brown, Renate Starr, Brenda Aguilar, Alfonso Brito, Brenda Chang, Aniee Sarkissian, Lihong Weng, Michael Jensen, Michael E Barish, Behnam Badie, Stephen J Forman
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W2219167334
FWCI: 0.13
Cites:
Cited by: 4
Related to: 10